A phase 3, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in subjects with previously untreated metastatic renal cell carcinoma Meeting Abstract
| Authors: | Hammers, H.; Sternberg, C.; McDermott, D. F.; Larkin, J.; Ravaud, A.; Rini, B.; Sharma, P.; Bhagavatheeswaran, P.; Gagnier, P.; Motzer, R. |
| Abstract Title: | A phase 3, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in subjects with previously untreated metastatic renal cell carcinoma |
| Meeting Title: | 13th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 114 |
| Issue: | Suppl. S4 |
| Meeting Dates: | 2014 OCT 24-25 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2014-10-01 |
| Start Page: | 9 |
| End Page: | 9 |
| Language: | English |
| ACCESSION: | WOS:000344393900015 |
| PROVIDER: | wos |
| DOI: | 10.1111/bju.12941 |
| Notes: | Meeting Abstract -- 13th International Kidney Cancer Symposium -- OCT 24-25, 2014 -- Chicago, IL -- 4 -- SI -- Source: Wos |
